beta-d-N(4)-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus. Konishi K, Kusakabe S, Kawaguchi N, Shishido T, et al. Antiviral Res 2024 Jul 30:105977. doi: 10.1016/j.antiviral.2024.105977.

Read + Share

Amedeo Smart

Independent Medical Education

Konishi K, Kusakabe S, Kawaguchi N, Shishido T, et al. beta-d-N(4)-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus. Antiviral Res 2024 Jul 30:105977. doi: 10.1016/j.antiviral.2024.105977.
PMID: 39089332